149 related articles for article (PubMed ID: 8323180)
1. Congenital adrenal hyperplasia complicated by central precocious puberty: treatment with LHRH-agonist analogue.
Dacou-Voutetakis C; Karidis N
Ann N Y Acad Sci; 1993 May; 687():250-4. PubMed ID: 8323180
[TBL] [Abstract][Full Text] [Related]
2. Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog.
Soliman AT; AlLamki M; AlSalmi I; Asfour M
Metabolism; 1997 May; 46(5):513-7. PubMed ID: 9160816
[TBL] [Abstract][Full Text] [Related]
3. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy.
Pescovitz OH; Comite F; Hench K; Barnes K; McNemar A; Foster C; Kenigsberg D; Loriaux DL; Cutler GB
J Pediatr; 1986 Jan; 108(1):47-54. PubMed ID: 3080571
[TBL] [Abstract][Full Text] [Related]
4. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog.
Pescovitz OH; Comite F; Cassorla F; Dwyer AJ; Poth MA; Sperling MA; Hench K; McNemar A; Skerda M; Loriaux DL
J Clin Endocrinol Metab; 1984 May; 58(5):857-61. PubMed ID: 6368580
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin releasing hormone analog treatment in children with congenital adrenal hyperplasia complicated by central precocious puberty.
Güven A; Nurcan Cebeci A; Hancili S
Hormones (Athens); 2015; 14(2):265-71. PubMed ID: 25553759
[TBL] [Abstract][Full Text] [Related]
6. Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height.
Comite F; Cassorla F; Barnes KM; Hench KD; Dwyer A; Skerda MC; Loriaux DL; Cutler GB; Pescovitz OH
JAMA; 1986 May; 255(19):2613-6. PubMed ID: 3084811
[TBL] [Abstract][Full Text] [Related]
7. LHRH analog treatment of central precocious puberty complicating congenital adrenal hyperplasia.
Pescovitz OH; Cassorla F; Comite F; Loriaux DL; Cutler GB
Ann N Y Acad Sci; 1985; 458():174-81. PubMed ID: 3911847
[No Abstract] [Full Text] [Related]
8. Combined therapy with luteinizing hormone releasing hormone agonist (LHRHa) and growth hormone (GH) in central precocious puberty.
Volta C; Regazzi C; Ndaka J; Vitale R; Bernasconi S
Acta Biomed; 2005 Sep; 76(2):73-8. PubMed ID: 16350551
[TBL] [Abstract][Full Text] [Related]
9. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty.
Kamp GA; Manasco PK; Barnes KM; Jones J; Rose SR; Hill SC; Cutler GB
J Clin Endocrinol Metab; 1991 Feb; 72(2):301-7. PubMed ID: 1991801
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
Mansfield MJ; Beardsworth DE; Loughlin JS; Crawford JD; Bode HH; Rivier J; Vale W; Kushner DC; Crigler JF; Crowley WF
N Engl J Med; 1983 Nov; 309(21):1286-90. PubMed ID: 6415479
[TBL] [Abstract][Full Text] [Related]
11. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
[TBL] [Abstract][Full Text] [Related]
12. Precocious puberty associated with neurofibromatosis and optic gliomas. Treatment with luteinizing hormone releasing hormone analogue.
Laue L; Comite F; Hench K; Loriaux DL; Cutler GB; Pescovitz OH
Am J Dis Child; 1985 Nov; 139(11):1097-100. PubMed ID: 3933329
[TBL] [Abstract][Full Text] [Related]
13. Adult height in precocious puberty after long-term treatment with deslorelin.
Oerter KE; Manasco P; Barnes KM; Jones J; Hill S; Cutler GB
J Clin Endocrinol Metab; 1991 Dec; 73(6):1235-40. PubMed ID: 1955504
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty.
Crowley WF; Comite F; Vale W; Rivier J; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1981 Feb; 52(2):370-2. PubMed ID: 6780592
[TBL] [Abstract][Full Text] [Related]
15. Effect of deslorelin dose in the treatment of central precocious puberty.
Pescovitz OH; Barnes KM; Cutler GB
J Clin Endocrinol Metab; 1991 Jan; 72(1):60-4. PubMed ID: 1898743
[TBL] [Abstract][Full Text] [Related]
16. Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report.
Comite F; Cutler GB; Rivier J; Vale WW; Loriaux DL; Crowley WF
N Engl J Med; 1981 Dec; 305(26):1546-50. PubMed ID: 6458765
[TBL] [Abstract][Full Text] [Related]
17. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.
Manasco PK; Pescovitz OH; Feuillan PP; Hench KD; Barnes KM; Jones J; Hill SC; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1988 Aug; 67(2):368-72. PubMed ID: 3292562
[TBL] [Abstract][Full Text] [Related]
18. Intranasal LH-RH analogue treatment of precocious puberty.
Koehler B; Koehler M; Osuch-Jaczewska R
Exp Clin Endocrinol; 1988 Mar; 92(3):252-6. PubMed ID: 3075552
[TBL] [Abstract][Full Text] [Related]
19. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
[TBL] [Abstract][Full Text] [Related]
20. The central issue in precocious puberty.
Bertelloni S; Baroncelli GI; Saggese G
J Pediatr; 1997 Nov; 131(5):786. PubMed ID: 9403669
[No Abstract] [Full Text] [Related]
[Next] [New Search]
